0.1482

3.52% -0.0054

After Hours: .15 0.0018 +1.21%

AIM ImmunoTech Inc (AIM)

Overview News Price History Discussions Forecast Stock Split

AIM ImmunoTech Inc stock is traded at $0.1482, with a volume of 3.66M. It is down -3.52% in the last 24 hours and down -36.50% over the past month. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen, a drug of macromolecular ribonucleic acid molecule for the treatment of chronic fatigue syndrome. It is also developing Ampligen for the treatment of Hepatitis B and HIV, as well as patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd. for the evaluation and discussion of business relationships concerning a COVID-19 therapeutic and vaccine. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Previous Close:

$0.1536

Open:

$0.16

24h Volume:

3.66M

Relative Volume:

4.86

Market Cap:

$10.04M

Revenue:

$202.00K

Net Income/Loss:

$-28.96M

P/E Ratio:

-0.247

EPS:

-0.6

Net Cash Flow:

$-21.85M

1W Performance:

-26.60%

1M Performance:

-36.50%

6M Performance:

-53.07%

1Y Performance:

-65.93%

1-Day Range:

$0.1337

$0.16

1-Week Range:

$0.131

$0.1996

52-Week Range:

$0.131

$0.62

AIM ImmunoTech Inc Stock (AIM) Company Profile

Name

AIM ImmunoTech Inc

Sector

Healthcare (1183)

Industry

Biotechnology (679)

Phone

352 448 7797

Address

2117 SW Highway 484, Ocala, FL

Employee

Twitter

@AIMImmuno

Next Earnings Date

2024-12-15

Latest SEC Filings

AIM's Discussions on Twitter

Compare AIM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AIM AIM ImmunoTech Inc	0.1482	10.04M	202.00K	-28.96M	-21.85M	-0.60
VRTX Vertex Pharmaceuticals Inc	469.23	122.13B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	710.00	78.30B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	646.64	39.73B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	276.19	35.50B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.61	28.47B	3.30B	-501.07M	1.03B	-2.1146

AIM ImmunoTech Inc Stock (AIM) Latest News

09:07 AM

AIM ImmunoTech announces follow-up clinical study of Ampligen with FluMist - TipRanks

09:07 AM

09:04 AM

AIM ImmunoTech advances Ampligen for avian influenza vaccine - Investing.com

09:04 AM

08:52 AM

AIM ImmunoTech announces a planned follow-up clinical study - GlobeNewswire

08:52 AM

08:51 AM

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM's Ampligen® and AstraZeneca's FluMist® to address the recent avian influenza outbreaks - The Manila Times

08:51 AM

08:50 AM

4X Immune Response: AIM's Ampligen Breakthrough with AstraZeneca's FluMist Against Bird Flu - StockTitan

08:50 AM

Feb 06, 2025